
Lyra Therapeutics Inc is a biotechnology business based in the US. Lyra Therapeutics Inc shares (LYRA) are listed on the NASDAQ and all prices are listed in US Dollars. Lyra Therapeutics Inc employs 59 staff and has a trailing 12-month revenue of around $1.6 million.
How to buy Lyra Therapeutics Inc stock
- Open a stock trading account. Use our comparison table or choose from our Top Picks.
- Confirm your payment details. Fund your account with a bank transfer, debit card or credit card and take advantage of any signup bonuses.
- Search for the stock by name or ticker symbol – LYRA. It's that simple.
SoFi Invest
- Trade stocks for $0 and no annual fee
- Start trading with a $0 minimum deposit
- Get up to $1,000 when you fund a new account within 30 days
Robinhood
- Get free stock upon signup
- Earn 4% interest on uninvested cash with Robinhood Gold
- Get 1% match on contributions to a Robinhood IRA
tastyworks
- $0 commissions on stocks and ETFs
- $0 closing commissions on stock and ETF options
- Get $200 in US stocks when you open and fund an account with min. $2,000 for 3+ mos.
Lyra Therapeutics Inc stock price (NASDAQ: LYRA)
Use our graph to track the performance of LYRA stocks over time.Lyra Therapeutics Inc shares at a glance
Latest market close | $2.67 |
---|---|
52-week range | $2.35 - $8.18 |
50-day moving average | $3.16 |
200-day moving average | $4.95 |
Wall St. target price | $17.75 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-3.29 |
Buy Lyra Therapeutics Inc stocks from these brokerages
Compare special offers, low fees and a wide range of types of investments among top trading platforms.Information on this page is for educational purposes only. Finder is not an advisor or brokerage service, and we don't recommend investors to trade specific stocks or other investments.
Finder is not a client of any featured partner. We may be paid a fee for referring prospective clients to a partner, though it is not a recommendation to invest in any one partner.
Is it a good time to buy Lyra Therapeutics Inc stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Lyra Therapeutics Inc price performance over time
Historical closes compared with the close of $2.67 from 2023-01-27
1 week (2023-01-24) | -6.32% |
---|---|
1 month (2022-12-30) | -14.97% |
3 months (2022-10-31) | -43.07% |
6 months (2022-07-29) | -58.86% |
1 year (2022-01-28) | -23.71% |
---|---|
2 years (2021-01-29) | -74.74% |
3 years (2020-01-27) | N/A |
5 years (2018-01-27) | N/A |
Lyra Therapeutics Inc financials
Revenue TTM | $1.6 million |
---|---|
Gross profit TTM | $-29,409,000 |
Return on assets TTM | -36.58% |
Return on equity TTM | -77.86% |
Profit margin | 0% |
Book value | $2.93 |
Market capitalisation | $88.2 million |
TTM: trailing 12 months
Lyra Therapeutics Inc share dividends
We're not expecting Lyra Therapeutics Inc to pay a dividend over the next 12 months.
Lyra Therapeutics Inc share price volatility
Over the last 12 months, Lyra Therapeutics Inc's shares have ranged in value from as little as $2.35 up to $8.18. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Lyra Therapeutics Inc's is -0.4224. This would suggest that Lyra Therapeutics Inc's shares have been inversely-correlated to the average (for this exchange) – so when the broader market trended up or down, Lyra Therapeutics Inc has bucked the trend.
Lyra Therapeutics Inc overview
Lyra Therapeutics, Inc. , a clinical-stage therapeutics company, focuses on the development and commercialization of novel integrated drug and delivery solutions for the localized treatment of patients with ear, nose, and throat diseases. It's XTreo technology platform is designed to deliver medicines directly to the affected tissue for sustained periods with a single administration. The company's product candidates include LYR-210, an anti-inflammatory implantable drug matrix for the treatment of chronic rhinosinusitis (CRS), which is in Phase II clinical trial; and LYR-220 for CRS patients with and without nasal polyps. The company was formerly known as 480 Biomedical, Inc. and changed its name to Lyra Therapeutics, Inc. in July 2018.
Lyra Therapeutics Inc in the news
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Lyra Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Frequently asked questions
What percentage of Lyra Therapeutics Inc is owned by insiders or institutions?Currently 1.156% of Lyra Therapeutics Inc shares are held by insiders and 78.479% by institutions. How many people work for Lyra Therapeutics Inc?
Latest data suggests 59 work at Lyra Therapeutics Inc. When does the fiscal year end for Lyra Therapeutics Inc?
Lyra Therapeutics Inc's fiscal year ends in December. Where is Lyra Therapeutics Inc based?
Lyra Therapeutics Inc's address is: 480 Arsenal Way, Watertown, MA, United States, 02472 What is Lyra Therapeutics Inc's ISIN number?
Lyra Therapeutics Inc's international securities identification number is: US55234L1052 What is Lyra Therapeutics Inc's CUSIP number?
Lyra Therapeutics Inc's Committee on Uniform Securities Identification Procedures number is: 55234L105
More guides on Finder
-
How to buy TXO Energy (TXO) stock
Everything we know about the TXO Energy IPO, plus information on how to buy in.
-
How to buy Brera (BREA) stock
Everything we know about the Brera IPO, plus information on how to buy in.
-
How to invest in the S&P 500
What you need to know about investing in the leading indicator for the overall US stock market.
-
How to buy IPO stock
Buying an IPO is as simple as buying any other stock, but not every trading platform offers IPO stocks.
-
How to buy Novo Integrated Sciences stock
Steps to owning and managing NVOS, with 24-hour and historical pricing before you buy.
-
How do ETFs work?
Your simple and straightforward guide to ETFs, how they work and the different types available.
-
What is stock lending?
Find out how stock lending works, the extra income you could potentially earn and the risks you should be aware of. Plus, compare stock trading platforms that offer stock lending.
-
How to buy SONDORS (SODR) stock when it goes public
Everything we know about the SONDORS IPO, plus information on how to buy in.
-
How to buy Bullfrog AI Holdings (BFRG) stock when it goes public
Everything we know about the Bullfrog AI Holdings IPO, plus information on how to buy in.
-
How to research stocks
Learn about stock analysis and how to use it to find the right company to buy.
Ask an Expert